Navigation Links
Boston Scientific Completes $1.05 Billion Senior Notes Offering
Date:8/13/2013

NATICK, Mass., Aug. 13, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) completed a public offering of $1.05 billion aggregate principal amount of its senior notes under the company's shelf registration statement.  The public offering consists of $600 million of 2.650% notes due October 1, 2018 and $450 million of 4.125% notes due October 1, 2023.  

The company previously announced that it intends to use the net proceeds from the offering, together with borrowings under its recent $400 million term loan facility, to redeem all or a portion of its (i) 5.450% notes due June 15, 2014, of which $600 million aggregate principal amount was outstanding as of the date hereof (the "June 2014 Notes"), and (ii) 4.500% notes due January 15, 2015, of which $850 million aggregate principal amount was outstanding as of the date hereof (the "January 2015 Notes"), and to pay related fees, expenses and premiums.   Following the completion of the offering, on August 13, 2013 the company provided the trustee with redemption notices to redeem all of the June 2014 Notes and the January 2015 Notes on September 12, 2013.  The company expects to record an after-tax one-time charge of approximately $45 million (or $0.03 per share) during the third quarter of 2013 associated with the redemption, which the company noted was not included in its previously announced GAAP earnings guidance.  This charge will not impact the company's adjusted earnings.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. 


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Boston Scientific Announces Results For Second Quarter Ended June 30, 2013
2. American Laboratory Trading Continues Steady Growth with Expansion in Boston
3. Affordable Scrum Training in Boston,MA by Conscires Agile Practices
4. Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston
5. The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA
6. Verified Clinical Trials (VCT) Will Co-Present With SAFE-BioPharma At Bio-IT World April 10th In Boston, MA Exploring Identity Management In eClinical Trials
7. Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center
8. Local Leaders Convene in Boston to Share Industry Best Practices in Second “Business of Big Data” Summit
9. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
10. Boston College researchers unique nanostructure produces novel plasmonic halos
11. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2012 Financial Results on January 29th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical solutions ... the Company closed its previously announced private placement ... W. Schuler , Birchview Fund LLC and several ... offering expenses.  The proceeds will be used for ...
(Date:12/24/2014)... 2014 “Preparative & Process Chromatography ... Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), Accessories, ... - Forecasts to 2019” provides a detailed overview ... market trends, and strategies impacting the preparative and ...
(Date:12/24/2014)... Boston, MA (PRWEB) December 23, 2014 Earlier ... James L. Sherley, director of the Adult Stem Cell Technology ... overlooked and under appreciated unique property of adult tissue stem ... Misunderstood in the Past, Important for the Future,” embodied the ...
(Date:12/24/2014)... 23, 2014 On Friday, December 19, ... Omnibus and Continuing Resolution Appropriations Act of 2015, which ... to receive funding through the Congressionally Directed Medical Research ... The Hydrocephalus Association (HA), working in conjunction with its ...
Breaking Biology Technology:Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2
... May 2, 2011 Cyberonics, Inc. (Nasdaq: CYBX ... first implant of its AspireSR™ seizure response product on April ... of Professors Paul Boon and Dirk Van Roost and their ... was received by a patient with ictal tachycardia (heart rate ...
... 2011 Today Divine Skin Inc. (OTC Bulletin Board: ... its DS Laboratories line for hair and skin. The company ... the United States. It estimates an average of $300 per ... With well-developed online, luxury, pharmaceutical, and specialty channels, Divine Skin,s ...
... MUNICH, May 2, 2011 Saladax Biomedical, Inc., a ... to achieve the promise of personalized medicine for new ... European commercialization team to expand its European presence. ... and Sales, members of Saladax,s European commercialization team include: ...
Cached Biology Technology:Cyberonics Announces First Implant of AspireSR™ Seizure Response Product in European Trial 2Cyberonics Announces First Implant of AspireSR™ Seizure Response Product in European Trial 3Divine Skin Announces Four Deals for Explosive Distribution Growth 2Divine Skin Announces Four Deals for Explosive Distribution Growth 3Saladax Biomedical, Inc. Announces European Commercialization Team 2Saladax Biomedical, Inc. Announces European Commercialization Team 3
(Date:1/22/2015)... Jan. 21, 2015  Analyst Report Issued by Small Cap IR. ... showed that planet-wide, transactions at merchants on the leading payment ... number of credit, debit, and prepaid cards reached 6.54 billion.  ... of fraudulent card usage in 2012, and credit and debit ...
(Date:12/24/2014)... , Dec. 23, 2014  Since its launch in December 2014, the ... eliminate the pain of trying to remember their usernames and ... fused to their smartphones. To assist people who have struggled ... company that created 1U and focuses on redefining identity, announced ...
(Date:12/19/2014)... 18, 2014 Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) ... North America Perimeter Security Systems Market" report to their ... The North American perimeter security market is estimated to grow ... the U.S. market holds a larger share in this market, ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3
... 7, 2008 -- Oncolytics Biotech Inc. (TSX: ONC, ... group led by Dr. Richard Vile of the ... published the results of its work testing the ... reovirus and cyclophosphamide in vivo. The paper, ...
... and Institute of Medicine (IOM) today released SCIENCE, EVOLUTION, ... a comprehensive and up-to-date picture of the current scientific ... classroom. Recent advances in science and medicine, along ... past 150 years, have reinforced evolution,s role as the ...
... which will report on significant advances in all aspects ... genetic diversity and crop improvement. Tropical Plant Biology ... in Springers publishing portfolio. The first issue is ... cover the most rapidly advancing aspects of tropical plant ...
Cached Biology News:Scientific evidence supporting evolution continues to grow 2Scientific evidence supporting evolution continues to grow 3Springer launches Tropical Plant Biology 2
... This special concentrated jetSI 10 nM ... delivery into mouse brain as described in: ... Alfama, C. Giovannangeli, J.-P. Behr, and B.-A. ... gene expression in the mouse brain at ...
... a fluorescein-conjugated jetSI-ENDO (excitation ... 520 nm), the powerful siRNA ... used to determine the transfection ... delivery and trafficking of siRNAs. ...
... Cell and Tissue Staining Kits are intended ... range of histological and cytological specimens. These ... antibodies manufactured by either R&D Systems or ... on the formation of the Avidin-Biotin Complex ...
... wide range of hands-on techniques that are ... all areas of protein chemistry and molecular ... illustrates just how valuable this book will ... introduce the theoretical background of a method ...
Biology Products: